2026 NPPES data Clinical & Laboratory Dermatological Immunology Physician NPI 1952374209 MD
Verify on CMS →

LEERA BRICENO, MD

Clinical & Laboratory Dermatological Immunology Physician in NORTH EASTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
462
Medicare Part D claims · 230 beneficiaries · Clinical & Laboratory Dermatological Immunology Physician avg: 755
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$485.79
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LEERA BRICENO, MD reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 462 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
462
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LEERA BRICENO, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

LEERA BRICENO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LEERA BRICENO, MD?

Below national average

NPI registry status

Active

Issued 02/08/2006

NPI 1952374209

Primary specialty

Clinical & Laboratory Dermatological Immunology Physician

Rare

63 US NPIs in this specialty

Medicare Part D claims

462 39% vs specialty avg

2023 prescription claims

Specialty avg: 755

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Clinical & Laboratory Dermatological Immunology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Clinical & Laboratory Dermatological Immunology Physician share within Massachusetts

1. Clinical & Laboratory Dermatological Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Clinical & Laboratory Dermatological Immunology Physician share within Massachusetts

Medicare quality performance — MIPS

LEERA BRICENO, MD's 2023 MIPS final score plotted against the Clinical & Laboratory Dermatological Immunology Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Clinical & Laboratory Dermatological Immunology Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Clinical & Laboratory Dermatological Immunology Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LEERA BRICENO, MD appears in the CMS NPPES registry as a Clinical & Laboratory Dermatological Immunology Physician provider holding MD credentials at 31 ROCHE BROS WAY, NORTH EASTON, MA, 02356, with a listed phone of (508) 535-3376. NPI 1952374209 was issued on 02/08/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRICENO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 462 prescription claims written by this provider, covering 230 Medicare beneficiaries and totaling roughly $300K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Clinical & Laboratory Dermatological Immunology Physician is a narrow specialty nationwide, with 63 enrolled providers across 29 states and an average of 755 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

31 ROCHE BROS WAY
NORTH EASTON, MA 02356

Provider Details

NPI 1952374209
Specialty Clinical & Laboratory Dermatological Immunology Physician
Credentials MD
Gender Female
NPI Issued 02/08/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Hospital and facility affiliations

Facilities where LEERA BRICENO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SOUTH SHORE DERMATOLOGY PHYSICIANS PC
NORTH EASTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LEERA BRICENO, MD. Source: openpaymentsdata.cms.gov.

Total received

$486

Largest payer

UCB, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to LEERA BRICENO, MD. To verify LEERA BRICENO, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

LEERA BRICENO, MD — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 462 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

462
Total Claims
$300K
Total Drug Cost
230
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
495
Total Day Supply
13,176
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$281K
Generic Drug Cost
$19K
Antibiotic Claims
20

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
0.94
Gender Split
73% female / 27% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LEERA BRICENO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
63
Valacyclovir
Valacyclovir Hcl
42
Nystatin
40
Betamethasone Dipropionate
34
Metronidazole
29
Triamcinolone Acetonide
29
Clobetasol Propionate
25
Fluocinolone Acetonide
20
Dupixent Syringe
Dupilumab
19
Calcipotriene
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Clinical & Laboratory Dermatological Immunology Physician Overview

How LEERA BRICENO, MD fits within the Clinical & Laboratory Dermatological Immunology Physician landscape nationally.

63
Clinical & Laboratory Dermatological Immunology Physician Providers in US
29
States with Clinical & Laboratory Dermatological Immunology Physician
755
Avg Claims per Provider

LEERA BRICENO, MD's 462 claims are below the specialty average of 755.

Nearby Clinical & Laboratory Dermatological Immunology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as BRICENO.

Compare Clinical & Laboratory Dermatological Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LEERA BRICENO, MD's specialty?
LEERA BRICENO, MD specializes in Clinical & Laboratory Dermatological Immunology Physician and practices in NORTH EASTON, Massachusetts. Credentials: MD.
How much does LEERA BRICENO, MD prescribe under Medicare Part D?
In 2023, LEERA BRICENO, MD wrote 462 Medicare Part D claims totaling $300K in drug costs for 230 beneficiaries.
What is LEERA BRICENO, MD's Medicare quality score?
LEERA BRICENO, MD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is LEERA BRICENO, MD located?
LEERA BRICENO, MD is located at 31 ROCHE BROS WAY, NORTH EASTON, MA, 02356. Phone: (508) 535-3376.
What is LEERA BRICENO, MD's NPI number?
LEERA BRICENO, MD's National Provider Identifier (NPI) is 1952374209, issued on 02/08/2006.
Does LEERA BRICENO, MD prescribe more brand-name or generic drugs?
LEERA BRICENO, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $281K in brand drug costs.
How many Clinical & Laboratory Dermatological Immunology Physician providers are there in the US?
There are 63 Clinical & Laboratory Dermatological Immunology Physician providers across 29 states in the US. The average Clinical & Laboratory Dermatological Immunology Physician provider writes 755 Medicare Part D claims per year.
What drugs does LEERA BRICENO, MD prescribe most often?
Based on 2023 Medicare Part D data, LEERA BRICENO, MD's most frequently prescribed drugs include Ketoconazole, Valacyclovir, Nystatin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LEERA BRICENO, MD accept Medicare?
LEERA BRICENO, MD appears in CMS Medicare data with 462 Part D claims and 230 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LEERA BRICENO, MD's credentials?
LEERA BRICENO, MD's NPI is 1952374209 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology